Pegloticase
Horizon Therapeutics
[]
dr. c langford on #yearinreview: mirror-rct adding mtx to improve #pegloticase efficacy and reduce anti-drug ab. it works, and the fda changed the label, but we need to weigh risks/benefits of mtx. #acr22 
Assc Prof @UTSWRheum in Dallas. I tweet what I find interesting, useful in clinical practice or on the boards. Read my blogs on https://t.co/skTdadNU3l; tweets are my own